[Experimental treatment of menopausal disorders by an estrogen-progestogen combination with the estrogen dominant or mixed and then a weak estrogen-progestogen combination].
Dorangeon
P
P
D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D015914:Estrogen Replacement Therapy / Q000379:methods*; D004967:Estrogens / Q000008:administration & dosage; D004997:Ethinyl Estradiol / Q000008:administration & dosage; D005040:Ethynodiol Diacetate / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008593:Menopause; D008656:Mestranol / Q000008:administration & dosage; D016896:Treatment Outcome
D003280:Contraceptives, Oral, Synthetic; D004967:Estrogens; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D008656:Mestranol